Novel promoter
    4.
    发明申请
    Novel promoter 审中-公开
    新型启动子

    公开(公告)号:US20060014931A1

    公开(公告)日:2006-01-19

    申请号:US10509565

    申请日:2003-06-19

    CPC分类号: C12N9/6421 A61K38/00

    摘要: Disclosing a promoter of the protease MDTS9, which is induced by TGF-β, which is involved in the metabolism of extracellular matrix, and in which the expression of the gene thereof is elevated in renal failure model animals, which promoter is useful as a tool for screening an agent for treating and/or preventing chronic renal failure, as well as a method for screening an agent for treating and/or preventing chronic renal failure by selecting an inhibitor of the promoter.

    摘要翻译: 公开了参与细胞外基质代谢的TGF-β诱导的蛋白酶MDTS9的启动子,其中在肾衰竭模型动物中其基因的表达升高,该启动子可用作工具 用于筛选用于治疗和/或预防慢性肾衰竭的药剂,以及通过选择启动子的抑制剂筛选用于治疗和/或预防慢性肾衰竭的药剂的方法。

    Metalloprotease having aggrecanase activity
    5.
    发明授权
    Metalloprotease having aggrecanase activity 失效
    具有聚集蛋白聚糖酶活性的金属蛋白酶

    公开(公告)号:US06716613B1

    公开(公告)日:2004-04-06

    申请号:US10009332

    申请日:2001-12-10

    IPC分类号: C12N948

    CPC分类号: C12N9/6489 A61K38/00

    摘要: This invention provides a novel metalloprotease having an aggrecanase activity which causes joint diseases, a gene coding for this metalloprotease, a promoter of the above metalloprotease, a method for screening a drug with the use of the above metalloprotease and a pharmaceutical composition for inhibiting degradation of proteoglycans, which comprises as the active ingredient a substance capable of inhibiting the aggrecanase activity of the above metalloprotease.

    摘要翻译: 本发明提供了具有引起关节疾病的聚集蛋白聚糖酶活性的新型金属蛋白酶,编码该金属蛋白酶的基因,上述金属蛋白酶的启动子,使用上述金属蛋白酶进行药物筛选的方法和抑制降解的药物组合物 蛋白多糖,其包含作为活性成分的能够抑制上述金属蛋白酶的聚集蛋白聚糖酶活性的物质。

    Method of Screening Antiobesity Agents
    6.
    发明申请
    Method of Screening Antiobesity Agents 审中-公开
    筛选抗肥胖剂的方法

    公开(公告)号:US20080102459A1

    公开(公告)日:2008-05-01

    申请号:US11792191

    申请日:2005-12-01

    IPC分类号: C12Q1/68

    摘要: The present invention relates to a method of screening for an antiobesity agent, an antidiabetic agent, and/or a hypolipidemic agent, comprising the step of analyzing whether or not a substance to be tested promotes an expression and/or a function of an angiopoietin-related growth factor. The present invention relates to a method of screening for an agent for promoting an expression and/or a function of an angiopoietin-related growth factor.

    摘要翻译: 本发明涉及筛选抗肥胖剂,抗糖尿病药和/或降血脂药的方法,包括分析待测试物质是否促进血管生成素-1的表达和/或功能的步骤, 相关生长因子。 本发明涉及筛选促进血管生成素相关生长因子的表达和/或功能的药剂的方法。

    Aggrecanase
    7.
    发明授权
    Aggrecanase 有权
    聚集蛋白聚糖酶

    公开(公告)号:US07193073B2

    公开(公告)日:2007-03-20

    申请号:US11285804

    申请日:2005-11-23

    摘要: A novel polypeptide, a polynucleotide encoding this polypeptide, an expression vector comprising this polynucleotide, a cell transfected with the expression vector, an antibody binding to the above polypeptide, a convenient screening method for obtaining an agent for treating joint diseases, and a process for manufacturing a pharmaceutical composition for treating joint diseases are disclosed.The polypeptide is a novel aggrecanase causative of joint diseases (particularly an OA disease).

    摘要翻译: 新的多肽,编码该多肽的多核苷酸,包含该多核苷酸的表达载体,用表达载体转染的细胞,与上述多肽结合的抗体,用于获得治疗关节疾病的药剂的方便的筛选方法,以及 公开了制备用于治疗关节疾病的药物组合物。 该多肽是一种新型的聚集蛋白聚糖酶,其是关节疾病(特别是OA病)。

    Aggrecanase
    8.
    发明授权
    Aggrecanase 有权
    聚集蛋白聚糖酶

    公开(公告)号:US07094590B2

    公开(公告)日:2006-08-22

    申请号:US10240545

    申请日:2001-12-17

    IPC分类号: C12N9/64 C07H21/04

    摘要: A novel polypeptide, a polynucleotide encoding this polypeptide, an expression vector comprising this polynucleotide, a cell transfected with the expression vector, an antibody binding to the above polypeptide, a convenient screening method for obtaining an agent for treating joint diseases, and a process for manufacturing a pharmaceutical composition for treating joint diseases are disclosed.The polypeptide is a novel aggrecanase causative of joint diseases (particularly an OA disease).

    摘要翻译: 新的多肽,编码该多肽的多核苷酸,包含该多核苷酸的表达载体,用表达载体转染的细胞,与上述多肽结合的抗体,用于获得治疗关节疾病的药剂的方便的筛选方法,以及 公开了制备用于治疗关节疾病的药物组合物。 该多肽是一种新型的聚集蛋白聚糖酶,其是关节疾病(特别是OA病)。